STOCK TITAN

Insider sale notice for EXEL (NASDAQ: EXEL) — 64,117 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Insider sale notice: A reporting person submitted a Form 144 indicating a proposed sale of 64,117 shares on 02/18/2026. The filing also reports prior sales of 42,422 shares on 02/17/2026 for $1,880,439.99.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a planned sale of 64,117 shares and prior sales of 42,422 shares.

The notice shows a proposed sale quantity of 64,117 shares dated 02/18/2026, and a prior reported sale of 42,422 shares on 02/17/2026 with proceeds of $1,880,439.99.

Timing and exact distribution methods are not detailed in the excerpt; subsequent public filings or broker confirmations would state execution details and proceeds recipients.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the EXEL Form 144 disclose about share quantity?

The Form 144 lists a proposed sale of 64,117 shares on 02/18/2026. It also reports prior sales of 42,422 shares on 02/17/2026 with proceeds shown as $1,880,439.99.

Who is the reporting person in the EXEL filing?

The filing names Julie Anne Smith with an Alameda, CA address as a reporting person. The excerpt lists broker details as Morgan Stanley Smith Barney LLC for transactions on 02/18/2026.

Does the Form 144 indicate how sale proceeds are treated?

The excerpt shows monetary figures for past transactions, including $1,880,439.99, but it does not state who receives proceeds or specific allocation; the filing lists transaction type as Stock Option Exercise.

What dates are tied to the reported transactions in the EXEL Form 144?

The proposed sale is dated 02/18/2026 and the prior sale occurred on 02/17/2026. Both dates appear next to the reported share quantities in the excerpt.
Exelixis Inc

NASDAQ:EXEL

View EXEL Stock Overview

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

11.40B
253.59M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
ALAMEDA